According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

In this webinar, sponsored by IPG Health, we will explore the role that cell and gene therapies can play in treating rare ...

Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.

Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...

or analytic assays/services The abstracts selected will include current CGT topics, challenges, and identified improvements or solutions, backed up by data (own or client sources can be anonymous) or ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program ...

CDMO Rentschler Biopharma is signalling its intent to cut down cell and gene therapy operations by shutting down its UK ...